⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,713.51
+0.30%
Nasdaq 100
29,532.82
+0.01%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.55
−0.25%
NYSE:TSM
$426.75
+1.55%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,121.15
−0.47%
Brent
$109.17
−0.05%
BTC
$82,446.72
+0.74%
ETH
$2,431.88
+1.11%
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,713.51
+0.30%
Nasdaq 100
29,532.82
+0.01%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.55
−0.25%
NYSE:TSM
$426.75
+1.55%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,121.15
−0.47%
Brent
$109.17
−0.05%
BTC
$82,446.72
+0.74%
ETH
$2,431.88
+1.11%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NYSE
› ABBV
A
AbbVie Inc
NYSE:ABBV
Healthcare
CBOE:SPESG
NASDAQ:NQUSLG
$288.87
+2.19%
Live
In session · ≈
AED 1,060.88
· Market cap
$510.47B
· Next earnings
Fri 30 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
AbbVie Inc · News · TradingHolo
ABBV news
Headlines tagged to this company
TH
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · 70 d ago
ZA
How Much Did Immunology Drugs Contribute to AbbVie's Q2 Performance?
Zacks Investment Research · 70 d ago
FO
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
Fool - Investing News · 70 d ago
TH
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · 74 d ago
ZA
ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?
Zacks Investment Research · 75 d ago
DE
AbbVie Inc. $ABBV Holdings Cut by Bill Few Associates Inc.
Defense World · 76 d ago
FO
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now
Fool - Investing News · 76 d ago
PR
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
PRNewsWire · 77 d ago
PR
AbbVie Reports Second-Quarter 2026 Financial Results
PRNewsWire · 82 d ago
PR
JUVÉDERM® Day Returns to U.S. on August 19
PRNewsWire · 82 d ago
PR
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
PRNewsWire · 84 d ago
PR
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
PRNewsWire · 84 d ago
← Previous
End of the feed